ALNYLAM PHARMACEUTICALS, INC. Annual Operating Income (Loss) in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Alnylam Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
  • Alnylam Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$76.9M, a 136% decline year-over-year.
  • Alnylam Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$188M, a 46.9% increase year-over-year.
  • Alnylam Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$282M, a 64.1% increase from 2022.
  • Alnylam Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$785M, a 10.8% decline from 2021.
  • Alnylam Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$709M, a 14.5% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$282M +$503M +64.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-15
2022 -$785M -$76.4M -10.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-15
2021 -$709M +$120M +14.5% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-15
2020 -$828M +$111M +11.8% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-23
2019 -$939M -$125M -15.3% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-10
2018 -$815M -$315M -62.9% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-11
2017 -$500M -$75.5M -17.8% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-13
2016 -$425M -$129M -43.4% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-14
2015 -$296M +$109M +26.9% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-15
2014 -$405M -$312M -336% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-15
2013 -$92.9M +$36.5M +28.2% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-12
2012 -$129M -$74.6M -136% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-13
2011 -$54.8M -$10.7M -24.4% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-20
2010 -$44.1M Jan 1, 2010 Dec 31, 2010 10-K 2013-02-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.